BioCentury | Aug 10, 2018
Clinical News

Strongbridge's Cushing syndrome candidate meets in Phase III

...ketoconazole, an inhibitor of cytochrome P450 family 11 subfamily B polypeptide 1 (CYP11B1), CYP17A1 and CYP21A2...
...polypeptide 1 (CYP11B1); CYP17A1; CYP21A2 Description: 2S,4R-enantiomer of ketoconazole, an inhibitor of CYP11B1, CYP17A1 and CYP21A2...
...P450 family 11 subfamily B polypeptide 1 (CYP11B1) Cytochrome P450 family 17 subfamily A polypeptide 1 (CYP17A1) Cytochrome P450 family 21 subfamily A polypeptide 2 (CYP21A2) Cushing's...
BioCentury | Oct 6, 2017
Financial News

NewLink, Strongbridge price follow-ons

...an inhibitor of cytochrome P450 family 11 subfamily B polypeptide 1 (CYP11B1) , CYP17A1 and CYP21A2...
...Genetics Corp. (NASDAQ:NLNK), Ames, Iowa Strongbridge Biopharma plc (NASDAQ:SBBP), Trevose, Pa. Jennie Walters Recorlev NewLink Genetics Corp. Strongbridge Biopharma plc CYP17A1 CYP21A2 Cytochrome...
BioCentury | Oct 4, 2017
Financial News

NewLink, Strongbridge price follow-ons

...an inhibitor of cytochrome P450 family 11 subfamily B polypeptide 1 (CYP11B1) , CYP17A1 and CYP21A2...
...P450 family 11 subfamily B polypeptide 1 (CYP11B1) Cytochrome P450 family 17 subfamily A polypeptide 1 (CYP17A1) Cytochrome P450 family 21 subfamily A polypeptide 2 (CYP21A2) Indoleamine...
BioCentury | Oct 17, 2015
Financial News

Strongbridge raises $25M in U.S. listing

...inhibitor of cytochrome P450 family 11 subfamily B polypeptide 1 ( CYP11B1 ), CYP17A1 and CYP21A2...
BioCentury | Oct 31, 2014
Financial News

Cortendo pulls Oslo IPO to mull U.S. listing, raises $11.3M

...inhibitor of cytochrome P450 family 11 subfamily B polypeptide 1 ( CYP11B1 ), CYP17A1 and CYP21A2...
BioCentury | Sep 1, 2014
Clinical News

NormoCort: Phase III started

...ketoconazole, an inhibitor of cytochrome P450 family 11 subfamily B polypeptide 1 (CYP11B1), CYP17A1 and CYP21A2...
Items per page:
1 - 6 of 6